全文获取类型
收费全文 | 10507篇 |
免费 | 344篇 |
国内免费 | 223篇 |
专业分类
耳鼻咽喉 | 183篇 |
儿科学 | 281篇 |
妇产科学 | 1007篇 |
基础医学 | 1218篇 |
口腔科学 | 171篇 |
临床医学 | 779篇 |
内科学 | 2006篇 |
皮肤病学 | 420篇 |
神经病学 | 624篇 |
特种医学 | 222篇 |
外科学 | 2230篇 |
综合类 | 111篇 |
一般理论 | 2篇 |
预防医学 | 638篇 |
眼科学 | 192篇 |
药学 | 586篇 |
中国医学 | 55篇 |
肿瘤学 | 349篇 |
出版年
2018年 | 93篇 |
2017年 | 90篇 |
2016年 | 134篇 |
2015年 | 144篇 |
2014年 | 137篇 |
2013年 | 253篇 |
2012年 | 254篇 |
2011年 | 267篇 |
2010年 | 227篇 |
2009年 | 175篇 |
2008年 | 282篇 |
2007年 | 334篇 |
2006年 | 410篇 |
2005年 | 432篇 |
2004年 | 419篇 |
2003年 | 414篇 |
2002年 | 460篇 |
2001年 | 307篇 |
2000年 | 267篇 |
1999年 | 208篇 |
1998年 | 118篇 |
1997年 | 120篇 |
1996年 | 129篇 |
1995年 | 166篇 |
1994年 | 139篇 |
1993年 | 141篇 |
1992年 | 185篇 |
1991年 | 172篇 |
1990年 | 160篇 |
1989年 | 209篇 |
1988年 | 178篇 |
1987年 | 212篇 |
1986年 | 145篇 |
1985年 | 205篇 |
1984年 | 145篇 |
1983年 | 142篇 |
1982年 | 179篇 |
1981年 | 160篇 |
1980年 | 137篇 |
1979年 | 145篇 |
1978年 | 131篇 |
1977年 | 140篇 |
1976年 | 129篇 |
1975年 | 146篇 |
1974年 | 117篇 |
1973年 | 108篇 |
1971年 | 80篇 |
1968年 | 128篇 |
1967年 | 101篇 |
1966年 | 87篇 |
排序方式: 共有10000条查询结果,搜索用时 187 毫秒
11.
Pharmacokinetics and pharmacodynamics of benazepril hydrochloride in patients with major proteinuria
Ch. Schweizer G. Kaiser W. Dieterle J. Mann 《European journal of clinical pharmacology》1993,44(5):463-466
Summary We have investigated whether the pharmacokinetics and pharmacodynamics of the ACE inhibitor benazepril hydrochloride are altered with proteinuria by studying 8 patients with major proteinuria of different causes who were given a single dose of 10 mg p.o.The maximum plasma concentration of benazepril was found between 0.5 and 2 h after dosing (median 1 h). Its elimination was almost complete within 6 h. Peak plasma levels of benazeprilat, the active metabolite of benazepril, were observed between 1 and 6 h (median 2.5 h). The elimination of benazeprilat from plasma was biphasic, with mean initial and terminal half-lives of 3.0 and 17.3 h, respectively. On average, the pharmacokinetic parameters of benazepril and benazeprilat in the patients did not differ from those in a historical control group of healthy volunteers, but intersubject variability in the AUC and half-lives of benazeprilat was greater in the patients.Plasma ACE was completely inhibited from 1.5 to 6 h after dosing, and at 48 h the mean inhibition was still 42 %. Plasma renin showed substantial intersubject variation. Mean supine blood pressure (systolic/diastolic) was reduced from baseline by a maximum of 18/13 mm Hg at 6 h. Proteinuria was diminished after benazepril in 7 patients.In conclusion, the results of this study suggest that proteinuria in the nephrotic range does not require a change in benazepril dosage. 相似文献
12.
Ch. Lenzen N. Roewer F. Wappler A. Köchling M. Steinfath J. Sgholz J. Schulte am Esch 《Acta anaesthesiologica Scandinavica》1995,39(3):343-346
Dantrolene seems to be the causal therapy in malignant hyperthermia (MH) crisis but the complex mechanisms of MH and dantrolene therapy are still not fully understood. The influence of dantrolene on ryanodine-induced contractures has been reported in animal studies only. In the present study 20 patients from] 7 families were tested for MH using the protocol of the European Malignant Hyperthermia Group. In addition ryanodine-induced contractures were evaluated following bolus application of 10.0 μmol · 1-1 ryanodine. After pretreatment with 1 μimol · 1-1 dantrolene ryanodine-provoked contractures developed significantly later in MHS (15.8±1.8 min) and MHN (46.0±4.2 min) muscle specimens than after ryanodine alone (MHS 4.8±0.7 min), (MHN 13.7±0.9 min). They were no longer observed in either group after pretreatment with 5 μimol · 1-1 dantrolene. We conclude that dantrolene is able to attenuate ryanodine-induced contractures dose-dependendy, and therefore it is speculated that dantrolene could specifically act at the ryanodine receptor binding site. 相似文献
13.
14.
15.
T. S. Lie M. Höfer Ch. Höhnke 《Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie》1987,372(1):893-894
Zusammenfassung Bei einem 55jährigen Mann wurde 7 Monate nach orthotoper Lebertransplantation eine Lungentuberkulose diagnostiziert. Die tuberculostatische Therapie erfolgte mit Isoniazid (3 x 0,2 g/Wo) und Ethambutol (1,6 g/d) über 11 Monate. Nach 3 Monaten waren keine Mycobakte rien mehr nachweisbar, und der Patient ist im 3. Jahr nach Transplantation ohne Zeichen einer aktiven Tuberkulose in gutem Gesundheitszustand bei guter Transplantatfunktion. Die Tuberculostatica-Dosierung sollte je nach Metabolisierungsleistung des Transplantats reduziert werden. Bei Beachtung dieses Kardinalpunktes könnte eine Tuberkulose nach Lebertransplantation erfolgreich behandelt werden. 相似文献
16.
17.
Dr. B. H.Ch. Stricker R. R. M. de Groot J. H. P. Wilson 《European journal of clinical pharmacology》1991,40(4):367-371
Summary In 1981 generalized anaphylaxis was registered on 166 occasions in Dutch general and academic hospitals. Clinical details of 120 of those patients revealed that in 107 anaphylaxis was either probable (n=90) or possible (n=17), whereas in 13 cases some other reaction than anaphylaxis had occurred. The series of confirmed cases contained 46 men and 61 women, with mean ages of 47 y and 48 y, respectively.There was a complete recovery in 102 patients and two patients died. Hypotension was present in 79 cases (74%), dyspnoea in 34 cases (32%) and a skin reaction, mainly urticaria, erythema or angioedema, was mentioned in 62 cases (58%). Most cases of anaphylaxis were drug-induced (76%), the main causes being the analgesic glafenine and contrast media. Glafenine was mentioned as the cause in 36% of all admissions for drug-induced anaphylaxis. Only 3.7% of cases had been reported to the voluntary reporting scheme of the Netherlands Centre for Monitoring of Adverse Reactions to Drugs.On the basis of reimbursement data, the risk of developing severe anaphylaxis to glafenine was estimated at 11.7–19.3-fold relative to indomethacin, and 13.4–20.2-fold relative to oral penicillins. 相似文献
18.
19.
20.
S. Champain Th. David Ch. Mazel A. Mitulescu W. Skalli 《European journal of orthopaedic surgery & traumatology : orthopedie traumatologie》2007,17(4):337-347
Adult low-grade isthmic spondylolisthesis is often treated by posterolateral lumbar fusion (PLF), with a certain rate of complications and non-return to work. Alternatives to fusion, like pars defect repair (PDR), were used with encouraging results in young populations and athletes but their outcomes were rarely evaluated for adult patients. This retrospective study quantitatively analysed the long-term outcomes in adult isthmic spondylolisthesis patients treated by PLF or PDR. At a mean follow-up of 9 years, clinical, socio-professional, radiological data and Stauffer-Coventry score were available for 59 patients (39 cases treated by PLF and 20 treated by PDR). The overall clinical outcomes were comparable in both populations (88% in the PDR and 80% in PLF group 1), with a larger proportion of excellent results (56% vs. 10%) and of return to work in the PDR group. Radiological quantitative analysis highlighted stationary evolution and comparable outcomes for the two groups, except for vertebral slip evolution and adjacent level degeneration rate. Abnormal kinematic patterns outlined for PLF patients 20% of pseudarthrosis and 42% of adjacent levels hypermobility and for PDR ones low mobility for the levels adjacent to instrumented vertebra in 40% of cases. Quantified analysis of biomechanical parameters interpreted altogether with clinical outcome, complications and economic burden of the patient, provided accurate objective data for a better appreciation of global outcome, allowing for a preliminary view on long-term outcomes after PDR in adult low-grade isthmic spondylolisthesis, which were not presented in literature until now. 相似文献